These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 4700692

  • 21. Persistence of mitotic circadian rhythm of a transplantable mammary carcinoma after 35 generations: its bearing on the success of treatment with endoxan.
    Badran AF, Echave Llanos JM.
    J Natl Cancer Inst; 1965 Aug; 35(2):285-90. PubMed ID: 5827236
    [No Abstract] [Full Text] [Related]

  • 22. Suppression of murine mammary carcinoma metastasis by the murine ortholog of breast cancer metastasis suppressor 1 (Brms1).
    Samant RS, Debies MT, Hurst DR, Moore BP, Shevde LA, Welch DR.
    Cancer Lett; 2006 Apr 28; 235(2):260-5. PubMed ID: 15978719
    [Abstract] [Full Text] [Related]

  • 23. [Pharmacokinetics of cyclophosphamide and cyclophosphamide metabolites in the mouse and their influence on the therapeutic effect of "activated" cyclophosphamide (4-hydroxycyclophosphamide) (author's transl)].
    Voelcker G, Haeglsperger R.
    Arzneimittelforschung; 1982 Apr 28; 32(6):639-47. PubMed ID: 7202370
    [Abstract] [Full Text] [Related]

  • 24. Exploratory studies of vitamin A and cyclophosphamide in tumor-bearing mice.
    Nathanson L, Maddock CL, Hall TC.
    J Clin Pharmacol J New Drugs; 1969 Apr 28; 9(6):359-73. PubMed ID: 5260199
    [No Abstract] [Full Text] [Related]

  • 25. [Induced resistance of experimental tumors to nitrosomethylurea].
    Krutova TV, Ostrovskaia LA.
    Vopr Onkol; 1982 Apr 28; 28(11):48-52. PubMed ID: 7147832
    [Abstract] [Full Text] [Related]

  • 26. [A method of primary selection of antitumor agents].
    Karaivanova MKh.
    Vopr Onkol; 1971 Apr 28; 17(2):62-6. PubMed ID: 5567711
    [No Abstract] [Full Text] [Related]

  • 27. Inhibition of C3H/He mouse mammary tumor growth by combined treatment with cyclophosphamide and polyadenylic-polyuridylic acid.
    Youn JK, Lacour F, Hue G.
    Cancer Res; 1982 Nov 28; 42(11):4706-11. PubMed ID: 7127305
    [Abstract] [Full Text] [Related]

  • 28. [In vitro and in vivo experiments on multiple-step cancer therapy; attack induction by alkylating cytostatics].
    von Ardenne M, Chaplain RA, Reitnauer PG.
    Dtsch Gesundheitsw; 1969 Sep 18; 24(38):1781-7. PubMed ID: 5376244
    [No Abstract] [Full Text] [Related]

  • 29. Combined chemotherapy of epithelial tumours.
    Abrahámová J, Jakoubková J, Havránková N.
    Neoplasma; 1970 Sep 18; 17(3):299-310. PubMed ID: 5430500
    [No Abstract] [Full Text] [Related]

  • 30. Transplantable mouse plasma cell tumors in experimental chemotherapy.
    Teller MN, Abraham D, Bowie M, Carbone PP.
    J Natl Cancer Inst; 1969 Jul 18; 43(1):123-31. PubMed ID: 5816022
    [No Abstract] [Full Text] [Related]

  • 31. Human breast carcinoma xenografts in nude mice.
    Li Z, Huang X, Li J, Ke Y, Yang L, Wang Y, Yao L, Lu Y.
    Chin Med J (Engl); 2002 Feb 18; 115(2):222-6. PubMed ID: 11940336
    [Abstract] [Full Text] [Related]

  • 32. Effects of endocrine regulation of growth of a mouse mammary tumor on its sensitivity to chemotherapy.
    Emerman JT, Siemiatkowski J.
    Cancer Res; 1984 Apr 18; 44(4):1327-32. PubMed ID: 6704951
    [Abstract] [Full Text] [Related]

  • 33. Acute in vivo resistance in high-dose therapy.
    Teicher BA, Ara G, Keyes SR, Herbst RS, Frei E.
    Clin Cancer Res; 1998 Feb 18; 4(2):483-91. PubMed ID: 9516940
    [Abstract] [Full Text] [Related]

  • 34. [Efficacy of attacks and combinations of attacks in the cancer multi-stage therapeutic concept in spontaneous mammary carcinoma of mice].
    von Ardenne M, Chaplain RA.
    Dtsch Gesundheitsw; 1970 Sep 17; 25(38):1776-9. PubMed ID: 5488750
    [No Abstract] [Full Text] [Related]

  • 35. Enhanced cures of spontaneous murine mammary tumors with surgery, combination chemotherapy, and immunotherapy.
    Martin DS, Hayworth PE, Fugmann RA.
    Cancer Res; 1970 Mar 17; 30(3):709-16. PubMed ID: 5425293
    [No Abstract] [Full Text] [Related]

  • 36. Experimental research in the influence of the endocrine status on the antiblastic activity of cytostatics.
    Zimel H.
    Neoplasma; 1967 Mar 17; 14(4):345-52. PubMed ID: 6063010
    [No Abstract] [Full Text] [Related]

  • 37. Influence of myelobromol on growth and metabolism of experimental tumours.
    Friborský V.
    Ther Hung; 1969 Mar 17; 17(1):23-7. PubMed ID: 5820143
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Effect of antineoplastic agents on the hypophysis-ovarian system in rats with transplantable mammary neoplasms].
    Vasnetsova SS, Bulkina ZP, Turkevich NM.
    Vopr Onkol; 1971 Mar 17; 17(8):85-90. PubMed ID: 5002549
    [No Abstract] [Full Text] [Related]

  • 40. Potential of the aminosterol, squalamine in combination therapy in the rat 13,762 mammary carcinoma and the murine Lewis lung carcinoma.
    Teicher BA, Williams JI, Takeuchi H, Ara G, Herbst RS, Buxton D.
    Anticancer Res; 1998 Mar 17; 18(4A):2567-73. PubMed ID: 9703911
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.